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ABSTRACT Mouse models play a crucial role in the study of human behavioral traits and diseases. Variation
of gene expression in brain may play a critical role in behavioral phenotypes, and thus it is of great
importance to understand regulation of transcription in mouse brain. In this study, we analyzed the role of
two important factors inﬂuencing steady-state transcriptional variation in mouse brain. First we considered
the effect of assessing whole brain vs. discrete regions of the brain. Second, we investigated the genetic
basis of strain effects on gene expression. We examined the transcriptome of three brain regions using
Affymetrix expression arrays: whole brain, forebrain, and hindbrain in adult mice from two common inbred
strains (C57BL/6J vs. NOD/ShiLtJ) with eight replicates for each brain region and strain combination. We
observed signiﬁcant differences between the transcriptomes of forebrain and hindbrain. In contrast, the
transcriptomes of whole brain and forebrain were very similar. Using 4.3 million single-nucleotide poly-
morphisms identiﬁed through whole-genome sequencing of C57BL/6J and NOD/ShiLtJ strains, we inves-
tigated the relationship between strain effect in gene expression and DNA sequence similarity. We found
that cis-regulatory effects play an important role in gene expression differences between strains and that the
cis-regulatory elements are more often located in 59 and/or 39 transcript boundaries, with no apparent
preference on either 59 or 39 ends.
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The mouse is widely used as a model organism for human behavior
studies because of the ability to manipulate its genome, to access brain
tissues, and to effectively measure mouse behavior phenotypes (Bucan
and Abel 2002). Among the many approaches to the dissection of the
genetic/molecular basis of behavior phenotypes, the study of tran-
scriptome in mouse brain has been commonly used and effective
(Fernandes et al. 2004; Nadler et al. 2006). Here, we aimed to assess
the role of two important factors on variation of gene expression: the
effects of strain and brain region. In a few studies authors have as-
sessed the effects of strain and/or brain region using microarray gene
expression data. In an early study on six brain regions of mouse strain
129SvEv and C57BL/6 investigators found that only 1% to 2% of genes
are differentially expressed across brain regions or strains (Pavlidis
and Noble 2001), but this result can be partly attributed to small
sample size and conservative thresholding. A study of hippocampal
gene expression in eight mouse strains reported .200 genes show-
ing strain differences (Fernandes et al. 2004). Su and coworkers
reported a gene expression atlas across multiple human and mouse
tissues including several mouse brain regions (Su et al. 2004). Re-
gional differences in gene expression have been shown to reﬂect the
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Volume 2 | February 2012 | 203embryologic imprint (Zapala et al. 2005). A larger study of gene
expression differences across seven brain regions and 10 strains identi-
ﬁed more than 9000 transcripts differentially expressed across brain
regions and more than 6000 transcripts showing strain effects (Nadler
et al. 2006). In addition, an anatomically comprehensive digital atlas by
in situ hybridization has been reported (Lein et al. 2007).
In this article, we studied strain and brain region effects from
different perspectives. First, assuming that previous knowledge is
limited and resources are insufﬁcient to assess gene expression in
a large number of discrete brain regions, we tested the effect of
assessing steady-state transcription in whole brain vs. in forebrain.
Second, to determine the effect of genetic diversity on differential gene
expression we evaluated two common inbred strains, C57BL/6J vs.
NOD/ShiLtJ. We selected these strains because they are among the
founders of new genetic resource populations known as the Collabora-
tive Cross and the Diversity Outcross (Collaborative Cross Consortium
2012; Svenson et al. 2012). The level of sequence similarity varies
widely across the genome ranging from complete identity by descent
in some regions to regions with haplotypes derived from different
house mouse subspecies (Yang et al. 2011). Furthermore, C57BL/6J
has been sequenced and used to assemble the mouse reference
genome (Waterston et al. 2002), and NOD/ShiLtJ is among the 17
inbred strains recently sequenced by the Wellcome Trust/Sanger
Institute (Keane et al. 2011).
We found that although there are signiﬁcant differences between
transcriptomes of forebrain and hindbrain, whole brain and forebrain
are very similar. Transcripts with stronger strain effects were
signiﬁcantly more likely to be located in genomic regions of high
genetic diversity between strains. Among approximately 4100 tran-
scripts with variable levels of sequence similarity between C57BL/6J
and NOD/ShiLtJ, those with high level of sequence similarity at the 59
and/or 39 region of the transcripts were less likely to be differentially
expressed. These ﬁndings strongly suggest that cis-regulatory effects
play an important role in gene expression difference between strains,
and the cis-regulatory elements are more often located in 59 and/or 39
transcript boundaries. Our data also suggest that there is no apparent
preference for cis-regulatory elements to be located on either 59 or 39
ends.
MATERIALS AND METHODS
Experimental design
The design of the study is summarized in Table 1. We studied brain
samples contrasting the effects of strain (C57BL/6J vs. NOD/ShiLtJ
adult male mice) and an acute drug treatment with a prototypical
second-generation antipsychotic (clozapine vs. vehicle) with four mice
per cell (16 mice in total). Three brain regions were studied: one
hemisphere was used intact (whole brain) and the other hemisphere
was separated into two portions, forebrain and hindbrain, as dictated
by randomization. Total RNA samples were thus available from 48
samples (2 strains · 2d r u gt r e a t m e n t s· 3 brain regions · 4 mice).
Because drug treatments showed little effect on gene expression var-
iation, essentially we consider our design as (2 strains · 3b r a i n
regions · 8 mice). Gene expression was measured by both Affymetrix
standard cartridge format (1.0ST arrays, each sample hybridized sep-
arately) and the newer peg format (1.1ST arrays, samples assayed in
two batches of 24 samples).
Mice
All procedures were conducted in strict compliance with US guide-
lines (National Research Council 1996) and approved by the Institu-
tional Animal Care and Use Committee of the University of North
Carolina. We used eight C57BL/6J and eight NOD/ShiLtJ male mice
aged 14 weeks. Male mice were studied to minimize estrous effects. All
mice were bred at UNC from a colony used to derive the U.S. lines of
the Collaborative Cross (Chesler et al. 2008). Mice have been bred for
four and six generations at the University of North Caroline and have
been separated for 6 years from the production colony at The Jackson
Laboratory. Animals were weaned at 3 weeks of age and singly housed
until the completion of the study. The housing room was on a 12-hr
light:12-hr dark schedule with lights on at 7:00 AM and temperature
maintained at 24  with 40% to 50% relative humidity. Mice were
housed in standard 20 cm · 30 cm ventilated polycarbonate cages
with laboratory grade Bed-O-Cob bedding. Water and Purina ProLab
IsoPro 3000 were available ad libitum.
Acute clozapine exposure
Animals were transferred from the animal facility to the laboratory
and given a 2-hour period to adapt to the new environment before
commencing drug treatment. Beginning at 10:00 AM, in randomized
order, one mouse every 10 min was administered either 4 mg/kg
clozapine or vehicle (0.9% saline) via intraperitoneal injection. The
clozapine dose was chosen based on the behavioral phenotyping lit-
erature (Duncan et al. 2006; Grauer et al. 2009; Porter and Prus 2009)
and because it had already been shown signiﬁcantly to alter the cor-
tical transcriptome of C57BL/6J mice in a pilot study. Four milligrams
of clozapine powder (Sigma-Aldrich) was dissolved in 100 mlo f2 0 %
glacial acetic acid, diluted with 9.875 ml of 0.9% saline, neutralized
with 25 ml of 10M NaOH, and injected at a volume of 10 ml/kg. Mice
were killed 3 hours after injection by cervical dislocation without
anesthesia and brains (with olfactory bulbs attached) were immedi-
ately removed.
Brain dissection
Brains were chilled for 30 sec in RNase-free 1· phosphate-buffered
saline and placed upright on a chilled aluminum block for dissection.
First, the cerebellum was removed and discarded by peeling back the
cerebellar hemispheres and cutting the cerebellar peduncles with
microscissors (supporting information, Figure S1). Second, the remain-
ing brain was divided into left and right hemispheres with a ﬁne razor
blade. Third, the hindbrain was removed by placing the tissue on its
n Table 1 Brain tissues analyzed by gene expression microarrays
Strain Treatment Mice Whole Brain Forebrain Hindbrain
NOD/ShiLtJ Vehicle 4 4 (2R 1 2L) 4 (2R 1 2L) 4 (2R 1 2L)
NOD/ShiLtJ Clozapine 4 4 (2R 1 2L) 4 (2R 1 2L) 4 (2R 1 2L)
C57BL/6J Vehicle 4 4 (2R 1 2L) 4 (2R 1 2L) 4 (2R 1 2L)
C57BL/6J Clozapine 4 4 (2R 1 2L) 4 (2R 1 2L) 4 (2R 1 2L)
Totals 16 16 (8R 1 8L) 16 (8R 1 8L) 16 (8R 1 8L)
R, right hemisphere; L, left hemisphere, determined at random.
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forceps (Fine Science Tools, part number FST 11370-31) into the
natural division between these brain regions (Figure S2). The forceps
were then closed, which acted to scoop out the hindbrain while leaving
the underlying cortex intact. For each mouse, the forebrain and hind-
brain from one hemisphere and the intact other hemisphere were
collected, weighed, snap frozen in liquid nitrogen and stored at
280  until RNA preparation. Whether the hemisphere was used intact
or dissected into forebrain and hindbrain was determined at random.
These dissections yielded a total of 48 tissues for microarray analysis.
RNA extraction
Total RNA was isolated from frozen brains using a Biopulverizer
(Biospec). Pulverized samples were placed in tubes containing 1 ml of
Trizol reagent (Invitrogen) and a stainless-steel bead. Samples were
shaken for 5 min on a Tissuelyzer apparatus (Mixer Mill 300;
QIAGEN) and incubated at room temperature for 5 min. We added
200 ml of chloroform (Fisher) and then samples were sequentially
shaken for 15 sec on a Tissuelyzer, incubated at room temperature
for 3 min, and centrifuged at 10,000 rpm for 15 min at 4 .T h e
supernatant was transferred to a gDNA Eliminator spin column
(RNeasy plus mini kit; QIAGEN) and processed according to the
manufacturer instructions. RNA was suspended in RNase-free water.
The concentration and purity of each sample was determined by
spectrophotometer (ND1000; Nanodrop) and conﬁrmed by Micro-
chip Gel Electrophoresis (Agilent), using Agilent 2100 Bioanalyzer
and RNA 6000 Nano Chip according to the manufactures’ instruction.
RNA integrity numbers of all samples were . 7. RNA samples were
stored at -80  until use.
Transcriptional proﬁling was performed using Affymetrix Gene
expression microarrays. Gene expression proﬁles were generated twice
for each sample using standard cartridge format (mouse gene 1.0ST
arrays, samples are hybridized separately over 2 days) and using the
newer peg format arrays (mouse gene 1.1S T arrays, samples processed
on two arrays of 24 samples each). Cartridge arrays were processed at
the UNC Functional Genomics Core and peg arrays at the Microarray
facility at the University of Pennsylvania. All samples were processed
with the GeneChip WT terminal labeling and hybridization protocol
in conjunction with the Ambion WT expression kit according the
manufacturers instructions. We veriﬁed that the probe content was
essentially identical between the 1.0ST and 1.1ST arrays.
Statistical analysis
Normalized expression levels of 35,556 transcripts were estimated
using robust multiarray average method (Irizarry et al. 2003) imple-
mented in Affymetrix gene expression console with default settings
(median polish and sketch-quantile normalization). A total of 6546
positive or negative control transcripts, which do not have mRNA
annotation, and additional 700 transcripts without mRNA annotation
were dropped. The remaining 28,310 transcripts were used in the
following analysis.
We used hierarchical clustering and principal component analysis
(PCA) to evaluate overall array performance. The 48 samples were
clustered using the R function hclust with the average link function.
The distance function used in clustering is deﬁned as follows. Let s1
and s2 be the expression proﬁles (across 28,310 transcripts) of two
samples. The distance between s1 and s2 is deﬁned as 1 2 jcorr(s1, s2)j.
PCA was conducted using the approach of Price et al. (2006).
A linear mixed effect model was used to jointly analyze the 48
samples, while accounting for the correlations between three brain
regions of each mouse. Let y be the expression of one gene in
n samples, y 5 ðy1; y2; ...;ynÞ
T. The linear mixed effect can be
written as:
y5Xb1Zu1e (1)
where Xb and Zu indicate the contributions from ﬁxed effect X and
random effect Z,a n de indicates the residual vector. Fixed effects
include brain region (forebrain, hindbrain, and whole brain), strain
(C57BL/6J vs. NOD/ShiLtJ), acute antipsychotic drug exposure (vehi-
cle vs. clozapine), array processing batch (two levels), and two-way
interactions between brain region, strain, and drug exposure. The
random effect includes a random intercept to account for the depen-
dencies among three brain regions of one mouse, which is equivalent
to assuming a compound symmetric structure of the 3 · 3c o v a r i a n c e
matrix for each mouse (i.e., the expression of one gene has the same
variance for the three brain regions and the same covariance for any
pair of brain regions). One may wish to relax these assumptions to
more general covariance structures; however, both simulations and
inclusion of spurious variable in real data show inﬂation of type I
error for any more complicated model (results not shown).
Initial inspection of the results from the linear mixed effect model
revealed conservative P-value distribution for some factors, implying
the existence of unaccounted confounding variables (Figure S3). Sur-
rogate variable analysis (Leek and Storey 2007) was used to address
this problem. First, we applied PCA to the residuals of the initial linear
mixed effect models. The ﬁrst ﬁve PCs for each array platform were
chosen as initial surrogate variables since they either explained a large
proportion of residual variance or explained a moderate amount of
variance and were correlated between platforms (Figure S4). Next, the
top 1000 genes that were most highly correlated with each initial
surrogate variable (in terms of the absolute value of correlation) were
selected and the reﬁned surrogate variable was calculated as the ﬁrst
PC of these 1000 genes. Finally, the ﬁve reﬁned surrogate variables
were included into the linear mixed effect models. The surrogate
variables removed the conservative pattern of P-value distributions.
The models with surrogate variables showed that the interactions
between drug and brain regions, and between drug and strain were
not signiﬁcant and hence these terms were dropped. For either array
platform, the ﬁnal model is:
y5b0 1b1batch1b2drug1b3strain1b4wb1b5hb
1b6wb·strain1b7hb·strain1
P5
j51gjsvj 1Zu1e (2)
where “batch,”“ drug,” and “strain” are indicators of second batch,
acute antipsychotic exposure, and strain NOD/ShiLtJ, respectively.
wb and hb are indicators of whole brain and hindbrain, and svi is the
j-th surrogate variable.
Using on the aforementioned linear mixed effect model, P-values
were calculated for each factor across all the 28,310 transcripts. We
had also ﬁtted linear ﬁxed effect models for each transcript in each
brain region. In general, linear ﬁxed effect models provided consistent
differential expression evidence as linear mixed effect models but were
less powerful since only 16 samples were analyzed each time in con-
trast to 48 samples used in linear mixed effect models (see Figure S7b
for an example).
Multiple testing across multiple transcripts were corrected to
control the false discovery rate (FDR) (Storey and Tibshirani 2003).
The proportion of equivalently expressed transcripts (p0) was calcu-
lated as twice of the proportion of transcripts with P-values . 0.5. For
a P-value cutoff p, the expected number of false discoveries (FD) was
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of discoveries (D) was the number of transcripts with P-values , p.
Finally, FDR was calculated as FD/D.
Functional category analysis
We used SAFE (Barry et al. 2005) for functional category_analysis of
2284 Gene Ontology (GO) terms (including 1581 biological process,
269 cellular component, and 434 molecular function categories) and
157 KEGG pathways. GO and pathway information were obtained
from R/bioconductor packages mogene10sttranscriptcluster.db. For
each factor of interest (i.e., brain region, strain, and drug), we sought
to identify the functional category enriched with the differentially
expressed transcripts. The association between each functional cate-
gory and a factor of interest was assessed by Wilcoxon rank-sum test,
and a permutation P-value was calculated by comparing the Wilcoxon
test statistic in the original data vs. the Wilcoxon test statistics from
the permuted data. Permutation P-value cutoff across multiple func-
tional categories was chosen by controlling FDR, and FDR was cal-
culated similarly as the case for differential expression.
Next we brieﬂy describe the calculation of Wilcoxon test statistics
for original data and permuted data. A large number of permutations
are needed to assess the statistical signiﬁcance of enrichment (Barry
et al. 2005), which renders linear mixed effect models computationally
infeasible. Therefore, we employed linear ﬁxed effect models. To assess
the signiﬁcance of drug or strain effects, we separately ﬁt a linear ﬁxed
effect model for each of the three brain regions:
y5a0 1a1 ·batch1a2 ·drug1a3 ·strain1
X5
j51bj ·svj 1e
(3)
The signiﬁcance of drug and strain was measured by the P-value
for hypothesis tests a1 5 0a n da2 5 0, respectively. Wilcoxon test
statistics were then calculated on the basis of the ranks of P-values of
the 28,310 transcripts. Next, we calculated Wilcoxon test statistics for
permuted data. Speciﬁcally, we shufﬂed the labels of drug so that four
of eight mice treated with clozapine/vehicle were assigned the label of
vehicle/clozapine, and thus obtained C8
4 ·C8
4 5 4900 permutations.
Wilcoxon test statistics were then calculated for each permutation.
Similarly, Wilcoxon test statistics of strain effect were calculated for
4900 permutations.
Let (u, v) be any pair of brain regions, and let the variables with
subscript u or v be subsets of the original variables in particular brain
region. We used the following model to test brain region effect.
yu 2yv 5a0 1a1 ·
 
batchu-batchvÞ1a2 ·strain1
X5
j51bjðsvju-svjvÞ1e (4)
Note that the main effects of strain and drug were canceled out in
the aforementioned equation. The strain effect left in the model
actually captured the interaction between strain and brain region. The
signiﬁcance of the hypothesis test a0 ¼ 0r e ﬂects the brain region
effect. We calculated Wilcoxon test statistic using the ranks of the
p-values testing hypothesis a0 ¼ 0 across 28,310 transcripts. Permuted
data were generated by randomly ﬂipping u and v 5000 times and
Wilcoxon test-statistics were calculated for each permutation.
Local DNA sequence similarity between C57BL/6J
and NOD/ShiLtJ
To determine the level of local sequence similarity between the two
inbred strains we used two complementary resources. Initially, we
used the local level of sequence similarity estimated based on the
analysis of high-density genotype data (Yang et al. 2011). This study
portioned the genome into 43,285 intervals on the basis of the 4-
gamete rule (Collaborative Cross Consortium 2012; Wang et al.
2012). Using the whole genome sequence for NOD/ShiLtJ (Keane
et al. 2011), we re-estimated the sequence similarity within these
43,285 intervals, calculated as the fraction of the base pairs where
the two strains have identical genotypes. The lengths of these 43,285
intervals and the distributions of the sequence similarity estimates are
illustrated in Figure 1.
RESULTS
Global view of gene expression reveals strong brain
region and strain effects
Table 1 summarizes the experimental design. All samples were ana-
lyzed using the standard Affymetrix 1.0ST cartridge format (one sam-
ple per cartridge) and the newer 1.1ST peg format (two runs of 24
samples). High-level descriptions of transcript expression using hier-
archical clustering, and PCA clearly indicated large expression differ-
ences by strain and brain region (Figure 2, Figure S5,a n dFigure S6).
Overall, expression in forebrain and whole brain were similar and
were both different from hindbrain (see patterns of clustering in
Figure 2). The ﬁrst PC, which accounted for approximately 90% of
the expression variance, was strongly associated with brain regions.
There were also substantial strain differences between C57BL/6J and
NOD/ShiLtJ. The effects caused by acute exposure to the antipsychotic
clozapine were considerably lesser. The average expression level and
standard deviation of the 28,310 transcripts were highly correlated
across the two platforms (Figure S8 and Figure S9). To simplify the
discussion, we only present the results on the basis of the gene ex-
pression data from 1.1ST array. The conclusions based on 1.0ST array,
which are similar, are presented in the supplementary materials.
Differential expression
We applied the linear mixed effect model (equation 2) to each of the
28,310 transcripts. FDRs were calculated along a series of P-value
cutoffs (Figure 3 and Table S1). For approximately 0.05 FDR, there
were 10,570 differentially expressed transcripts for forebrain vs. hind-
brain, 3896 transcripts for C57BL/6J vs. NOD/ShiLtJ, 834 transcripts
for whole brain vs. forebrain, and none for clozapine vs. vehicle. These
results were qualitatively similar to Figure 2D, where brain region
dominated PC1 and strain dominated PC2. Consistent with the results
of hierarchical clustering and PCA, there was considerable similarity
between whole brain and forebrain. Furthermore, 94.6% of transcripts
(789 of 834) differentially expressed in forebrain vs. whole brain were
also differentially expressed in forebrain vs. hindbrain (Figure 3A), as
expected given that whole brain consists of forebrain and hindbrain.
Compared with a previous transcriptional atlas (Su et al. 2004), dif-
ferentially expressed genes tended to have higher expression levels in
different brain tissues (Figure S10).
When there are large numbers of differentially expressed tran-
scripts, functional category analysis can assist the interpretation of
results by identifying larger-scale processes with expression alterations
in aggregate. Among the 2284 GO terms (FDR , 0.01), we identiﬁed
717 GO terms associated with brain region effect, 41 GO terms for
strain effect, and none for drug effect. No GO term was signiﬁcantly
associated with the contrast of forebrain vs. whole brain. The 717
brain region2related GO terms arose from the contrast of forebrain
vs. hindbrain (394 GO terms: 275 BPs, 76 MFs, and 43 CCs) or whole
brain vs. hindbrain [488 GO terms: 317 Biological Processes (BPs), 88
Molecular Functions (MFs), and 83 Cellular Components (CCs)], with
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expected by chance (Fisher’s exact test P-value , 2e-16), which
again supports the similarity between whole brain and forebrain
transcriptomes. The most signiﬁcant GO terms differentially
expressed between forebrain and hindbrain included BP (membrane
lipid metabolic process, gliogenesis, nerve2nerve synaptic transmis-
sion, and neuron development); MF (transmembrane receptor pro-
tein kinase activity and lipid binding); and CC (plasma membrane
and postsynaptic membrane). The top 122 GO terms associated with
brain regions (P-value , 2e-4 in either forebrain vs. hindbrain or
whole brain vs. hindbrain) are listed in Table S3. Strain effects were
assessed in forebrain, hindbrain, and whole brain separately for the
functional category analysis. Although genetic background altered
the expression of thousands of transcripts, only 41 GO terms (20
CCs 1 21 MFs, Table S4) were enriched with such transcripts, which
suggested the strain signature transcripts were relatively evenly dis-
tributed across GO terms. All the 41 GO terms were identiﬁed in
hindbrain. No GO term was associated with strain effect in either
forebrain or whole brain.
Functional category analysis of the 157 KEGG pathways identiﬁed
no pathway associated whole brain vs. forebrain comparison, strain
effect, or drug effect. As shown in Table S5, there were 35 pathways
signiﬁcantly associated (FDR , 0.01) with the contrast of whole brain
vs. hindbrain (21 pathways) and/or forebrain vs. hindbrain (21 path-
ways), with 7 pathways overlap (expect 3, Fisher’s exact test P-value ¼
0.01). Interestingly, we identiﬁed not only pathways related to crucial
behavioral processes (e.g. long-term potentiation; Figure 4) and long-
term depression (Figure S12), but also cancer-related pathways such
as melanoma (Figure S13), and thyroid cancer (Figure S14). A careful
examination of genes of melanoma pathway that were differentially
expressed between brain regions revealed several growth factors, such
as platelet-derived growth factor (Pdgfd)a n dﬁbroblast growth factors
(Fgf1, Fgf16, Fgf18,a n dFgf22), which suggested that these growth
factors are involved in both brain function and tumor growth, al-
though further studies are needed to illuminate the details. In addi-
tion, the hindbrain is known to differ from forebrain/whole brain in
that it contains nuclei producing melanin (i.e., substantia nigra)
(Kim et al. 2006) and thyroid-releasing hormone (hypothalamus)
(Alkemade et al. 2008), though the links to melanoma and thyroid
cancer pathways remain unclear.
The impact of genetic background
A total of 3896 transcripts were differentially expressed between
C57BL/6J and NOD/ShiLtJ (in forebrain) using a P-value cutoff of
Figure 1 Array-level, unsupervised descriptive summaries of gene expression using hierarchical clustering (A and B) and PCA (C and D) via two
Affymetrix assay formats, standard 1.0ST cartridges (A and C) and 1.1ST peg/geneTitan format (B and D). NOD, NOD/ShiLtJ; B6, C57BL/6J mouse
strains. Cloz, acute clozapine exposure; Veh, exposure to vehicle without clozapine. Individual mice are indicated by a three-letter code followed by
a letter indicating the brain region: W, whole brain; F, forebrain; H, hindbrain.
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expressed between brain regions (Figure 3B). The strain effect was
different between forebrain and hindbrain for 778 transcripts (P-value
0.002 and FDR 0.057; Figure 3C) but was remarkably similar between
whole brain and forebrain for the vast majority of transcripts. This
conclusion was conﬁrmed by comparing P-values of strain effects
assessed in forebrain and whole brain separately using linear ﬁxed
effect models (Figure S7a).
The wide variation in local levels of genetic diversity between
C57BL/6J and NOD/ShiLtJ provides us with an opportunity to test
whether the bulk of strain effects are attributable to local eQTL (gene
expression quantitative trait loci), which is commonly referred to as
cis-eQTL. To test this hypothesis, we grouped transcripts on the basis
of the local level of genomic sequence similarity with the expectation
that transcripts located in regions with very high sequence similarity
between C57BL/6J and NOD/ShiLtJ were less likely to be differentially
Figure 3 Sequence similarities across
blocks. (A) Distribution of sequence
similarities given the similarities are
smaller than 1. The two vertical lines
correspond to sequence similarity of
0.999 and 0.9999, respectively. (B)
A smooth scatter plot of log10(block
length) and log10(1-similarity). In log10
scale, those blocks with sequence simi-
larity 1 are not shown, which are sum-
marized in (C). (D) Distribution of block
lengths.
Figure 2 Overlap of the differentially expressed genes
(FDR , 0.05) with respect to several experimental fac-
tors for 1.1ST arrays. (A) Overlap of the genes differen-
tially expressed between brain regions. (B) Overlap of
the genes with brain region effect of hindbrain brain vs.
forebrain, strain effect, and/or their interaction. (C)
Overlap of genes with any brain region effect and/or
strain effect.
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considered, 27,081 transcripts had non-missing genomic sequence
similarity information (Wang et al. 2012; Yang et al. 2011). One
transcript might have multiple genomic sequence similarity levels
(in different regions of this transcript) that were not consistent. We
deﬁne “consistency” as cases in which there is only one unique se-
quence similarity measurement or the standard deviation of all se-
quence similarity measurements is smaller than 0.001.
Among the 27,081 total transcripts analyzed, 22,963 transcripts
had consistent sequence similarity measurements along the gene body
and 10-kb ﬂanking regions. For these transcripts, we calculated the
average genomic sequence similarity over the gene body and ﬂanking
regions. The other group includes the remaining 4118 transcripts with
inconsistent sequence similarity along the gene body and ﬂanking
regions. Transcripts with consistent sequence similarities were sig-
niﬁcantly less likely to show strain effects in forebrain (Figure 5, P ,
2.2e216). The effect of variable levels of sequence similarity along
chromosomes is shown in Figure S15. We further divided the 4118
transcripts with variable DNA similarity measurements into four
groups on the basis of on the identity-by-descent (IBD) status at 59
and 39 of the transcript (i.e., as genotype identity .0.999 based on
sequencing data). This level of similarity (i.e., 1 SNP per 10 kb) is
consistent with previous estimates for recent IBD from a recent an-
cestor and the error rate of the whole genome sequencing effort
(Keane et al. 2011). We observed a general trend in which transcripts
that were IBD at 59 and/or 39 end were signiﬁcantly less likely to
exhibit strain effects in forebrain gene expression than those without
IBD (Figure 6, P ¼ 1.5e24). Moreover, another group of genes evi-
denced an interaction between strain and hindbrain effects. Tran-
scripts with uniformly higher DNA similarities were signiﬁcantly
less likely to have strain · hindbrain interaction effects (P ¼ 1.3e27,
Figure S16). Among transcripts with variable genomic sequence sim-
ilarity, those IBD at 59 and/or 39 end were less likely to exhibit strain ·
hindbrain interaction effects (Figure S17).
DISCUSSION
The experiment reported here had two major goals. First, we assessed
steady-state transcription in whole brain and two more speciﬁcb r a i n
regions. Second, we studied the impact of strain genetic background
on expression levels. In addition, we also studied the effects of acute
clozapine exposure on gene expression in mouse brain.
Figure 4 Heat map of the expression of the 77 probesets belonging to pathway “Long-term potentiation.” Each column of the heat map
corresponds to a sample and each row corresponds to a probeset. In the column labels, B and D indicates strain of B6 and NOD, respectively,
and F, H, and W indicate forebrain, hindbrain, and whole brain, respectively.
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For many developmental processes and diseases, detailed neuropath-
ological studies have localized the brain region in which to survey the
transcriptome. For most neuropsychiatric disorders, however, detailed
knowledge of the appropriate brain region to study is lacking or, as
with the many psychotropic medications including antipsychotics, the
effects might be general across many brain regions. Thus, without
more precise knowledge, an investigator might wish to assess tran-
scription in a relatively large region of brain. In mouse, forebrain is
often chosen for behavioral and psychopharmacology research given
its superﬁcial similarity to human prefrontal cortex. Alternatively, if
localization is imprecise, a transcriptional survey might target one
hemisphere. We were unable to identify studies that directly addressed
this choice.
In direct and careful comparisons, we found considerable simi-
larities between transcription in forebrain and whole brain. This is
partly attributable to the fact that “whole brain” consisted of forebrain
and hindbrain. Indeed, 94.6% of transcripts differentially expressed in
forebrain vs. whole brain were also differentially expressed in fore-
brain vs. hindbrain, and no functional categories emerged in compar-
isons of whole brain vs. forebrain.
There were major effects of strain. The strains we studied (C57BL/6J
and NOD/ShiLtJ) are superﬁcially quite similar. Both are commonly
used classical inbred strains, and over 93% of each genome is of Mus
musculus domesticus origin (Yang et al. 2007). However, this overall
comparison is misleading because there are considerable differences
between these strains at a regional level (Yang et al. 2011). Support-
ing this contention, approximately 14% of all transcripts were differ-
entially expressed between C57BL/6J and NOD/ShiLtJ in forebrain.
Genes with differential expression between strains did not form in-
terpretable pathways, which suggests that strain effects do not result
from larger scale processes (e.g., selection) operating on the level of
biological processes. We hypothesized that the bulk of strain effects
might be attributable to cis-eQTL, and then the genes differentially
expressed between two strains tend to have lower level of DNA
sequence similarity between the two strains. Therefore a functional
category is associated with strain effect only if a signiﬁcant propor-
tion of the genes in this category have lower level of DNA sequence
similarity between the two strains, which was not observed in
C57BL/6J and NOD/ShiLtJ.
Our results conﬁrmed the association between the DNA sequence
similarity between C57BL/6J and NOD/ShiLtJ and differential ex-
pression between these two strains. Transcripts with higher DNA
similarities between C57BL/6J and NOD/ShiLtJ were much less likely
to show strain effects. Moreover, among the 4118 transcripts with
varying similarities between strains across their lengths, transcripts
that were IBD at 59 and/or 39 ends were much less likely to exhibit
strain effects. The similar effect of sequence diversity in the 59 and 39
of the genes suggest that polymorphisms in both the promoter regions
and in the 39UTRs have similar potential to explain gene expression
variation, an important consideration when ascribing SNPs associated
with biomedical traits to nearby gene. These analyses also indicate that
number and strength of cis-eQTL should be higher in populations
with high levels of genetic diversity such as the CC and DO (Bottomly
et al. 2012; Collaborative Cross Consortium 2012; Svenson et al.
2012). This result easily explains the high number of cis-eQTL iden-
tiﬁed in experiments using incipient CC lines (Aylor et al. 2011;
Figure 5 Comparisons of the categories of transcripts on the basis of
strain effect P-value at forebrain and DNA similarity, for the 22,963
transcripts with consistent genomic sequence similarity estimates be-
tween NOD/ShiLtJ and C57BL/6J along the gene body and 10-kb
ﬂanking regions. In the upper panel, the transcripts were grouped
on the basis of DNA similarity and within each group we compared
proportion of transcripts with different P-values. In the lower panel, the
transcripts were grouped on the basis of the strain effect P-values and
within each group we compared the proportion of transcripts with
different sequence similarities.
Figure 6 Comparisons of the categories of transcripts based on strain
effect P-value at forebrain and IBD status at 59 and 39 regions for the
4118 transcripts with variable genomic sequence similarity estimates
between NOD/ShiLtJ and C57BL/6J in the gene body. Here IBD is
deﬁned as genotypic identity . 0.999 using Sanger sequencing data.
In the upper panel, the transcripts were grouped on the basis of IBD
location and within each group we compared proportion of transcripts
within different P-value ranges. The vertical bars indicated the 95%
conﬁdence intervals. In the lower panel, the transcripts were grouped
on the basis of strain effect P-values and within each group, we com-
pared the proportion of transcripts with different IBD location statuses.
210 | W. Sun et al.Durrant et al. 2011) and suggests that gene expression could be under
genetic control in most genes in that population.
Finally, we assessed the impact of acute clozapine exposure on gene
expression. In contrast to the robust strain and brain region effects, no
transcript or functional categories is signiﬁcantly associated with acute
clozapine exposure. The lack of signiﬁcance could have been attribut-
able to insufﬁciently large sample size or technical aspect of clozapine
dosing (e.g., insufﬁcient dose or duration of treatment). Intriguingly,
four top-ranked biological processes from functional category analyses
(hemopoiesis, immune system development, hemopoietic or lymphoid
organ development, and myeloid cell differentiation) immediately sug-
gest a connection to clozapine-induced agranulocytosis: a potentially
lethal adverse effect of clozapine treatment in humans. Moreover,
clozapine-induced weight gain is an additional adverse effect, and
multiple relevant biological processes were altered in hindbrain, e.g.,
regulation of generation of precursor metabolites and energy.
In summary, we provide gene expression data and analytical
results of comparing mouse gene expression in three brain regions
and two strains. We conclude that gene expression measured in whole
brain is highly similar to gene expression measured in forebrain and
DNA variations around the gene, especially at 59 or 39 regions of the
gene have large impact on gene expression.
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